What if your gut bacteria could become medicine?

In this episode, a UGA microbiologist, Greg Phillips, reveals how engineered probiotic E. coli can produce L-dopa, the frontline treatment for Parkinson’s, directly inside the gut. We explore the gut–brain connection, the power of the microbiome, and how living microbes could become the next generation of drug delivery systems.

From World War I probiotic strains to modern genetic engineering, this episode takes you inside a bold new frontier of microbiome-based medicine.

Dive into the world of chromatin and epigenetics with Dr. Zachary Lewis, an associate professor at the UGA Department of Microbiology. His research explores how chromatin structure and other epigenetic mechanisms shape genome organization, function, and long-term stability in eukaryotic cells. He particularly studies chromatin within fungal pathogens. In this episode, Dr. Lewis breaks down why these molecular systems matter, how they influence fungal disease, and the cutting-edge methods his lab uses to study them.

This episode takes us inside the lab of Dr. Drew Etheridge, an associate professor in the UGA Department of Cellular Biology. He walks us through his scientific path and his current work on endocytosis in Trypanosoma cruzi. This parasite is often overlooked, yet it is becoming increasingly prevalent in the United States as it moves north from Central and South America.